Literature DB >> 31874737

A rodent model of partial intestinal diversion: a novel metabolic operation.

Rafael Alvarez1, Darleen A Sandoval2, Randy J Seeley2.   

Abstract

BACKGROUND: Metabolic surgery is safe and the most effective therapy for obesity and its co-morbidities. New procedures may allow for better tailoring of metabolic surgery to the individual patient.
OBJECTIVE: To evaluate the impact, comparative effectiveness, and mechanisms of the partial intestinal diversion (PID), vertical sleeve gastrectomy (VSG), and the combination of PID and VSG on weight and glucose regulation.
SETTING: University research facility, United States.
METHODS: Three cohorts of high-fat diet-induced obese male rats were randomized to distal PID (DPID), proximal PID (PPID), VSG, VSG and DPID (VSG/DPID), or sham operation (Sham). Animals were followed for 11 (cohort 1) or 10 (cohorts 2 and 3) weeks. Outcomes included weight and composition, food intake, glucose metabolism, lipids, bile acids, and energy balance. Statistical comparisons were performed using Tukey's multiple comparison test applied to analysis of variance.
RESULTS: DPID and not PPID resulted in significant weight and body fat reductions relative to Sham. Improved glucose tolerance was seen in all surgical groups though this reached statistical significance for only DPID and VSG compared with Sham. Improvements in baseline glucose and insulin, corresponding insulin resistance, and plasma lipids were noted in DPID compared with Sham. Though the magnitude of weight and body composition changes and metabolic benefit tended to be larger for VSG relative to DPID, it only reached statistical significance for lipids. VSG and VSG/DPID resulted in similar outcomes. Markedly reduced food intake occurred after VSG and more modestly after DPID. Stool caloric content was higher in DPID relative to all groups.
CONCLUSIONS: DPID is an effective metabolic operation resulting in notable weight and fat loss and metabolic improvement relative to sham-operated rodents. Interestingly, combining VSG with DPID added little additional benefit to the effects of VSG.
Copyright © 2019 American Society for Bariatric Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Animal study; Bariatric surgery; Bile acids; Body composition; Energy balance; Glucose metabolism; Lipid metabolism; Metabolic surgery; PID; Partial intestinal diversion; VSG; Vertical sleeve gastrectomy; Weight loss; Weight loss surgery

Mesh:

Substances:

Year:  2019        PMID: 31874737      PMCID: PMC7024579          DOI: 10.1016/j.soard.2019.10.026

Source DB:  PubMed          Journal:  Surg Obes Relat Dis        ISSN: 1550-7289            Impact factor:   4.734


  38 in total

1.  Sleeve gastrectomy plus side-to-side jejunoileal anastomosis for the treatment of morbid obesity and metabolic diseases: a promising operation.

Authors:  John Melissas; Anastasia Peppe; John Askoxilakis; Efstathios Dimitriadis; John Grammatikakis
Journal:  Obes Surg       Date:  2012-07       Impact factor: 4.129

2.  Bypassing the duodenum does not improve insulin resistance associated with diet-induced obesity in rodents.

Authors:  Tammy L Kindel; Paulo J F Martins; Stephanie M Yoder; Ronald J Jandacek; Randy J Seeley; David A D'Alessio; Silvana Obici; Patrick Tso
Journal:  Obesity (Silver Spring)       Date:  2010-10-28       Impact factor: 5.002

3.  Effects of sleeve gastrectomy in high fat diet-induced obese mice: respective role of reduced caloric intake, white adipose tissue inflammation and changes in adipose tissue and ectopic fat depots.

Authors:  Anne-Sophie Schneck; Antonio Iannelli; Stéphanie Patouraux; Déborah Rousseau; Stéphanie Bonnafous; Beatrice Bailly-Maitre; Ophélia Le Thuc; Carole Rovere; Patricia Panaia-Ferrari; Rodolphe Anty; Albert Tran; Philippe Gual; Jean Gugenheim
Journal:  Surg Endosc       Date:  2013-10-03       Impact factor: 4.584

4.  A comparison of rodent models of vertical sleeve gastrectomy.

Authors:  Rafael Alvarez; Alfor G Lewis; Mouhamadoul H Toure; Randy J Seeley
Journal:  Surg Obes Relat Dis       Date:  2018-07-02       Impact factor: 4.734

5.  Deactivation of the NLRP3 inflammasome in infiltrating macrophages by duodenal-jejunal bypass surgery mediates improvement of beta cell function in type 2 diabetes.

Authors:  Dong Wu; Zhi-Bo Yan; Yu-Gang Cheng; Ming-Wei Zhong; Shao-Zhuang Liu; Guang-Yong Zhang; San-Yuan Hu
Journal:  Metabolism       Date:  2017-11-10       Impact factor: 8.694

6.  Weight-independent changes in blood glucose homeostasis after gastric bypass or vertical sleeve gastrectomy in rats.

Authors:  Adam P Chambers; Lene Jessen; Karen K Ryan; Stephanie Sisley; Hilary E Wilson-Pérez; Margaret A Stefater; Shrawan G Gaitonde; Joyce E Sorrell; Mouhamadoul Toure; Jose Berger; David A D'Alessio; Stephen C Woods; Randy J Seeley; Darleen A Sandoval
Journal:  Gastroenterology       Date:  2011-07-12       Impact factor: 22.682

7.  Carbohydrate content of post-operative diet influences the effect of vertical sleeve gastrectomy on body weight reduction in obese rats.

Authors:  Maximilian Bielohuby; Kerstin Stemmer; José Berger; Juliane Ramisch; Kathleen Smith; Jenna Holland; Kenneth Parks; Paul T Pfluger; Kirk M Habegger; Matthias H Tschöp; Randy J Seeley; Martin Bidlingmaier
Journal:  Obes Surg       Date:  2012-01       Impact factor: 4.129

8.  Duodenojejunal Bypass Leads to Altered Gut Microbiota and Strengthened Epithelial Barriers in Rats.

Authors:  Po-Jen Yang; Wei-Shiung Yang; Hsiao-Ching Nien; Chiung-Nien Chen; Po-Huang Lee; Linda Chia-Hui Yu; Ming-Tsan Lin
Journal:  Obes Surg       Date:  2016-07       Impact factor: 4.129

9.  A multicenter, randomized efficacy study of the EndoBarrier Gastrointestinal Liner for presurgical weight loss prior to bariatric surgery.

Authors:  Ruben Schouten; Carianne S Rijs; Nicole D Bouvy; Wim Hameeteman; Ger H Koek; Ignace M C Janssen; Jan-Willem M Greve
Journal:  Ann Surg       Date:  2010-02       Impact factor: 12.969

10.  Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013.

Authors:  Marie Ng; Tom Fleming; Margaret Robinson; Blake Thomson; Nicholas Graetz; Christopher Margono; Erin C Mullany; Stan Biryukov; Cristiana Abbafati; Semaw Ferede Abera; Jerry P Abraham; Niveen M E Abu-Rmeileh; Tom Achoki; Fadia S AlBuhairan; Zewdie A Alemu; Rafael Alfonso; Mohammed K Ali; Raghib Ali; Nelson Alvis Guzman; Walid Ammar; Palwasha Anwari; Amitava Banerjee; Simon Barquera; Sanjay Basu; Derrick A Bennett; Zulfiqar Bhutta; Jed Blore; Norberto Cabral; Ismael Campos Nonato; Jung-Chen Chang; Rajiv Chowdhury; Karen J Courville; Michael H Criqui; David K Cundiff; Kaustubh C Dabhadkar; Lalit Dandona; Adrian Davis; Anand Dayama; Samath D Dharmaratne; Eric L Ding; Adnan M Durrani; Alireza Esteghamati; Farshad Farzadfar; Derek F J Fay; Valery L Feigin; Abraham Flaxman; Mohammad H Forouzanfar; Atsushi Goto; Mark A Green; Rajeev Gupta; Nima Hafezi-Nejad; Graeme J Hankey; Heather C Harewood; Rasmus Havmoeller; Simon Hay; Lucia Hernandez; Abdullatif Husseini; Bulat T Idrisov; Nayu Ikeda; Farhad Islami; Eiman Jahangir; Simerjot K Jassal; Sun Ha Jee; Mona Jeffreys; Jost B Jonas; Edmond K Kabagambe; Shams Eldin Ali Hassan Khalifa; Andre Pascal Kengne; Yousef Saleh Khader; Young-Ho Khang; Daniel Kim; Ruth W Kimokoti; Jonas M Kinge; Yoshihiro Kokubo; Soewarta Kosen; Gene Kwan; Taavi Lai; Mall Leinsalu; Yichong Li; Xiaofeng Liang; Shiwei Liu; Giancarlo Logroscino; Paulo A Lotufo; Yuan Lu; Jixiang Ma; Nana Kwaku Mainoo; George A Mensah; Tony R Merriman; Ali H Mokdad; Joanna Moschandreas; Mohsen Naghavi; Aliya Naheed; Devina Nand; K M Venkat Narayan; Erica Leigh Nelson; Marian L Neuhouser; Muhammad Imran Nisar; Takayoshi Ohkubo; Samuel O Oti; Andrea Pedroza; Dorairaj Prabhakaran; Nobhojit Roy; Uchechukwu Sampson; Hyeyoung Seo; Sadaf G Sepanlou; Kenji Shibuya; Rahman Shiri; Ivy Shiue; Gitanjali M Singh; Jasvinder A Singh; Vegard Skirbekk; Nicolas J C Stapelberg; Lela Sturua; Bryan L Sykes; Martin Tobias; Bach X Tran; Leonardo Trasande; Hideaki Toyoshima; Steven van de Vijver; Tommi J Vasankari; J Lennert Veerman; Gustavo Velasquez-Melendez; Vasiliy Victorovich Vlassov; Stein Emil Vollset; Theo Vos; Claire Wang; XiaoRong Wang; Elisabete Weiderpass; Andrea Werdecker; Jonathan L Wright; Y Claire Yang; Hiroshi Yatsuya; Jihyun Yoon; Seok-Jun Yoon; Yong Zhao; Maigeng Zhou; Shankuan Zhu; Alan D Lopez; Christopher J L Murray; Emmanuela Gakidou
Journal:  Lancet       Date:  2014-05-29       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.